Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michael V. Pilepich"'
Autor:
Min Zhang, Elizabeth H. Hammond, R. Jeffrey Lee, Arnab Chakravarti, R. Scott Bermudez, Alan Pollack, Alex Ho, Li Yan Khor, Michael V. Pilepich, Yoshiyuki Suzuki, William U. Shipley, Howard M. Sandler
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 73:1033-1042
Purpose To examine the prognostic value of nuclear and cytoplasmic survivin expression in men with locally advanced prostate cancer who were enrolled in Radiation Therapy Oncology Group (RTOG) protocol 8610. Methods and Materials RTOG 8610 was a Phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c9104c47373dd2ac43daf86213baa99
https://doi.org/10.1016/j.ijrobp.2008.06.1489
https://doi.org/10.1016/j.ijrobp.2008.06.1489
Autor:
Karen E. Bremner, Andre Konski, Deborah Watkins-Bruner, Murray Krahn, J. Robert Beck, Michael V. Pilepich, Eric J. Sherman
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 63:788-794
Purpose: To evaluate the cost-effectiveness of adding hormone therapy to radiation for patients with locally advanced prostate cancer, using a Monte Carlo simulation of a Markov Model. Methods and Materials: Radiation Therapy Oncology Group (RTOG) pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09d8bd949026049698029f78cb3ddd1a
https://doi.org/10.1016/j.ijrobp.2005.03.010
https://doi.org/10.1016/j.ijrobp.2005.03.010
Autor:
Philip Rubin, Michelle DeSilvio, Colleen A. Lawton, Mack Roach, William T. Sause, Michael V. Pilepich, William U. Shipley, Harvey B. Wolkov
Publikováno v:
International journal of radiation oncology, biology, physics. 64(4)
Purpose: We examined overall and disease-specific survival outcomes both from the time of initial treatment and from the start of salvage hormone therapy (HT), by the extent of disease progression at the time salvage HT was started in patients treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c2388279e056941fd367b290502ab5b
https://pubmed.ncbi.nlm.nih.gov/16427211
https://pubmed.ncbi.nlm.nih.gov/16427211
Autor:
Colleen A. Lawton, Michael V. Pilepich, Philip Rubin, Jiandong Lu, William U. Shipley, Harvey B. Wolkov, Mitchell Machtay, Mack Roach, William T. Sause, K. Heydon
Publikováno v:
International journal of radiation oncology, biology, physics. 54(5)
To compare, by a secondary analysis, the therapeutic benefits of androgen suppression in protocol prostate cancer patients with relapse after radiotherapy (RT) for locally advanced disease who, in the Phase III trial beginning in 1987, were assigned
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f5748ae4520be98b3170e9b31297718
https://pubmed.ncbi.nlm.nih.gov/12459350
https://pubmed.ncbi.nlm.nih.gov/12459350